Nifedipine and Nimodipine Competitively Inhibit Uridine Kinase and Orotidine-Phosphate Decarboxylase: Theoretical Relevance to Poor Outcome in Stroke

Neurorehabilitation and Neural Repair

Volumn 14, Issue 3, 2000, Pages 237-241

  Najarian, Thomas ^a   Traut, Thomas W ^b  

^a Medical Online   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium channel blocker; Dihydropyridine; Nifedipine; Nimodipine; Stroke outcome

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYTIDINE; NIFEDIPINE; NIMODIPINE; OROTIDINE 5' PHOSPHATE DECARBOXYLASE; URIDINE; URIDINE KINASE;

ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; NERVE REGENERATION; NONHUMAN; PYRIMIDINE SYNTHESIS; STROKE;

ANIMALS; BINDING, COMPETITIVE; BRAIN; CALCIUM CHANNEL BLOCKERS; CELL MEMBRANE; CEREBROVASCULAR ACCIDENT; HUMANS; NEURONS; NIFEDIPINE; NIMODIPINE; OROTIDINE-5'-PHOSPHATE DECARBOXYLASE; PHARMACOKINETICS; RECOVERY OF FUNCTION; TREATMENT OUTCOME; URIDINE KINASE;

EID: 0033741060     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/154596830001400310     Document Type: Article

References (31)

1. Wahlgren N MacMahon D De Keyser J, et al. Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 1994; 4: 204–10.
2. Kaste M Fogelholm R Erila T, et al. A randomized double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke. Stroke 1994; 25: 1348–53.
3. Brott T Lu M Kothari R, et al. Hypertension and its treatment in the NINDS rt: PA stroke trial. Stroke 1998; 29: 1504–9.
4. Trovarelli G De-Medio G Dorman R, et al. Effect of cytidine-diphosphate choline (CDP-choline) on ischaemia-induced alterations of brain lipid in the gerbil. Neurochem Res 1981; 6: 821–33.
5. Di-Trapani G Fioravanti M. Citicoline in the treatment of cognitive and behavioral disorders in pathologic senile decline. Clin Ther 1991; 137: 403–13.
6. López G Coviella I Wurtman R. Enhancement by cytidine of membrane phospholipid synthesis. J Neurochem 1992; 59: 338–43.
7. Ropp PA Traut TW. Cloning and expression of a cDNA encoding uridine kinase from mouse brain. Arch Biochem Biophys 1994; 336: 105–12.
8. Han B-D Livingstone LR Pasek DJ, et al. Human UMP synthase: Expression, purification and characterization. Biochemistry 1995; 34: 10835–43.
9. Jones ME Kavipurapu PR Traut TW. Orotate phosphoribosyl-transferase: Orotidylate decarboxylase (Ehrlich ascites cell). Methods Enzymol 1978; 51: 155–67.
10. Davies P Simmonds H Singer B, et al. Plasma uridine as well as uric acid is elevated following fructose loading. In: Griesmacher A,etal, eds. Purine and pyrimidine metabolism in man. Vol IX. New York: Plenum Press, 1998: 31–5.
11. Yamamoto T Moriwaki Y Takahashi S, et al. Effect of glucose on the plasma concentration and urinary excretion of uridine and purine bases. Metabolism 1999; 48: 338–41.
12. Traut TW. Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 1994; 140: 1–22.
13. Geiger A Yamasaki S. Cytidine and uridine requirement of the brain. J Neurochem 1956; 1: 93–100.
14. Hogans A Guroff G Udenfriend S. Studies on the origin of pyrimidines for biosynthesis of neural RNA in the rat. J Neurochem 1971; 18: 1699–710.
15. Tremblay G Jimenez U Crandall D. Pyrimidine biosynthesis and its regulation in the developing rat brain. J Neurochem 1976; 26: 57–64.
16. Dierich A Wintzerith M Sarlieve L, et al. Biosynthesis pathways of nucleotides in different nerve cell cultures. J Neurochem 1980; 24: 1126–9.
17. Mascia L Cotrufo T Cappiello M, et al. Ribose 1-phosphate and inosine activate uracil salvage in rat brain. Biochim Biophys Acta 1999; 1472: 93–8.
18. Yuh I Yaoi T Watanabe S, et al. Up-regulated uridine kinase gene identified by RLCS in the ventral horn after crush injury to rat sciatic nerves. Biochem Biophys Res Commun 1999; 266: 104–9.
19. Breimer D Schellens J Soons P. Nifedipine: Variability in its kinetics and metabolism in man. Pharmacol Ther 1989; 44: 445–54.
20. Chamorro A Vila N Ascaso C, et al. Blood pressure and functional recovery in acute ischemic stroke. Stroke 1998; 29: 1850–3.
21. Adams H Brott T Crowell R, et al. Guidelines for the management of patients with acute ischemic stroke: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25: 1901–14.
22. Grossman E Messerli F Grodzicki T, et al. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 1996; 276: 1328–31.
23. Coviella Lopez GI Agut J von Borstel R, et al. Metabolism of cytidine (5′)-diphosphocholine (CDP-choline) following oral and intravenous administration to the human and the rat. Neurochem Int 1987; 11: 293–7.
24. Nalini G Hariprasa C Chandrasekaran AKP. A comparative study of serum deaminases in systemic rheumatic diseases. Br J Rheumatol 1993; 32: 1118–9.
25. Skeith K Wefuan J Oswald R, et al. Serum cytidine deaminase as a measure of disease activity in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 1993; 20: 1309–15.
26. Slingerland R van Gennip A Bodlaender J, et al. In situ cytidine deaminase activity and chromosome IP deletion in human neuroblastoma cells. Anticancer Res 1997; 17: 457–9.
27. Payne RC Cheng N Traut TW. Uridine kinase from Ehrlich ascites carcinoma: Purification and properties of homogeneous enzyme. J Biol Chem 1985; 260: 10242–7.
28. Rosenfeldt FL. Editorial: Metabolic supplementation with orotic acid and magnesium orotate. Cardiovasc Drugs Ther 1998; 12: 147–52.
29. Leyva A van Groeningen C Kraal I, et al. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity. Cancer Res 1984; 44: 5928–33.
30. Traut TW Payne RC. Dependence of the catalytic activities on the aggregation and conformation states of uridine 5′-phosphate synthase. Biochemistry 1980; 19: 6068–74.
31. Payne RC Traut TW. Regulation of the uridine kinase quaternary structure: Dissociation by the inhibitor CTP. J Biol Chem 1982; 257: 12485–8.